Salifluss

Salifluss is a muco-adhesive tablet developed for the symptomatic treatment of xerostomia (dry mouth). The product is designed to adhere to the oral mucosa, where it provides sustained lubrication and protection while simultaneously stimulating natural saliva production. Its formulation typically includes sialagogues such as malic acid, which trigger salivary flow through the stimulation of taste receptors, and xylitol, which supports oral health. Salifluss is marketed in the United Kingdom and Ireland by KoRa Healthcare, with Metis Healthcare serving as the Marketing Authorisation Holder. It is primarily regulated as a medical device (Class IIa) and is indicated for patients experiencing dry mouth due to various causes, including medication side effects, radiotherapy, or autoimmune conditions like Sjögren's syndrome.

Brand names

Salifluss